S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
NASDAQ:IOBT

IO Biotech - IOBT Institutional Ownership

$1.94
-0.06 (-3.00%)
(As of 03/27/2023 03:59 PM ET)
Add
Compare
Today's Range
$1.90
▼
$2.09
50-Day Range
$1.98
▼
$2.98
52-Week Range
$1.90
▼
$9.77
Volume
53,619 shs
Average Volume
75,944 shs
Market Capitalization
$55.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.50

Institutional Ownership Changes (13F Filings) for IO Biotech (NASDAQ:IOBT)

Current
Institutional Ownership
Percentage
53.23%
Number of
Institutional Buyers
(last 12 months)
8
Total
Institutional Inflows
(last 12 months)
$4.76 M
Number of
Institutional Sellers
(last 12 months)
3
Total
Institutional Outflows
(last 12 months)
$2.60 M
Skip Chart & View Institutional Buying and Selling Data

IOBT Institutional Buying and Selling by Quarter

Get IOBT Insider Trade Alerts

Want to know when executives and insiders are buying or selling IO Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

IO Biotech Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/15/2023Millennium Management LLC20,554$47K0.0%-46.4%0.071%
2/15/2023Morgan Stanley29,060$67K0.0%+31.7%0.101%
2/14/2023RA Capital Management L.P.1,127,260$2.59M0.1%-39.3%3.911%
2/13/2023Renaissance Technologies LLC24,200$56K0.0%+31.4%0.084%
2/10/2023Bank of America Corp DE1,854,185$4.27M0.0%+18,441.9%6.434%
11/15/2022Citadel Advisors LLC42,180$0.11M0.0%+192.4%0.146%
11/14/2022Renaissance Technologies LLC18,423$50K0.0%N/A0.064%
11/14/2022Psagot Value Holdings Ltd. Israel40,846$0.11M0.0%N/A0.142%
11/2/2022Victory Capital Management Inc.43,741$0.12M0.0%N/A0.152%
8/15/2022Millennium Management LLC46,231$0.22M0.0%-36.4%0.160%
5/17/2022Jane Street Group LLC14,280$76K0.0%N/A0.050%
5/13/2022Ergoteles LLC11,126$59K0.0%N/A0.039%
5/13/2022Vanguard Group Inc.62,234$0.33M0.0%-69.7%0.216%
2/15/2022Samsara BioCapital LLC1,120,437$7.17M1.4%N/A3.888%
2/15/2022Capital World Investors1,235,000$8.11M0.0%N/A4.286%
2/14/2022Soleus Capital Management L.P.672,734$4.31M0.4%N/A2.335%
2/14/2022Novo Holdings A S3,277,932$20.98M1.0%N/A11.376%
(Data available from 1/1/2016 forward)













IOBT Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of IOBT shares?

During the previous two years, 15 institutional investors and hedge funds held shares of IO Biotech. The most heavily invested institutionals were Novo Holdings A S ($20.98M), Capital World Investors ($8.11M), Samsara BioCapital LLC ($7.17M), Soleus Capital Management L.P. ($4.31M), Bank of America Corp DE ($4.27M), RA Capital Management L.P. ($2.59M), and Vanguard Group Inc. ($0.33M).Learn more on IOBT's institutional investors.

What percentage of IO Biotech stock is owned by institutional investors?

53.23% of IO Biotech stock is owned by institutional investors. Learn more on IOBT's institutional investor holdings.

Which institutional investors have been buying IO Biotech stock?

Of the 12 institutional investors that purchased IO Biotech stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Novo Holdings A S ($3.28M), Bank of America Corp DE ($1.84M), Capital World Investors ($1.24M), Samsara BioCapital LLC ($1.12M), Soleus Capital Management L.P. ($0.67M), Victory Capital Management Inc. ($43.74K), and Psagot Value Holdings Ltd. Israel ($40.85K).

How much institutional buying is happening at IO Biotech?

Institutional investors have bought a total of 8,319,235 shares in the last 24 months. This purchase volume represents approximately $45.12M in transactions.

Which IO Biotech major shareholders have been selling company stock?

The following institutional investors have sold IO Biotech stock in the last 24 months: RA Capital Management L.P. ($0.73M), Vanguard Group Inc. ($0.14M), and Millennium Management LLC ($44.27K).

How much institutional selling is happening at IO Biotech?

Institutional investors have sold a total of 917,726 shares in the last 24 months. This volume of shares sold represents approximately $2.60M in transactions.

This page (NASDAQ:IOBT) was last updated on 3/27/2023 by MarketBeat.com Staff